Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]
NYS Entity Status
NYS Filing Date
JUNE 27, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - MAIN STREET DEVELOPMENT GROUP, LLC
AROUND THE WEB
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
- Economic Study Ranks San Diego Near Top in Genomics Innovation
By Bruce V. Bigelow - Tuesday Jun 20, 2017
An economic impact study of San Diego’s emerging genomics industry counted 115 genomics-related companies operating in the region that directly employ over 10,000 people, and drive about $5.6 billion worth of annual economic benefits throughout the area. “San Diego is really end-to-end in genomics, from start to finish,” said Kirby Brady, who oversaw the study […]
- Still Living With the 'Riot Effect,' 50 Years Later
Tuesday Jul 11, 2017
Arson and looting in the guise of protest made Newark and Detroit what they are today.
- Worldpay Group, a British Payments Processor, Fields Two Possible Takeover Bids
By CHAD BRAY - Tuesday Jul 4, 2017
The company said that it had been contacted by Vantiv, a rival payments company based in Cincinnati, and by the banking powerhouse JPMorgan Chase.
- Disney Slapped With Lawsuit Over ‘Guardians of the Galaxy,’ ‘Avengers: Age of Ultron’ Effects
By Tim Kenneally, provided by
- Monday Jul 17, 2017
Visual effects firm says that Disney contracted with people who stole the technologyThe company was slapped with a lawsuit on Monday by a visual effects company, which claims that its technology was misappropriated for “Beauty and the Beast,” “Guardians of the Galaxy” and Avengers:“[I]n all of the film industry and media accolades about the record-breaking success of ‘Beauty and the Beast,’ and the acclaimed cutting-edge digital MOVA Contour technology that made the film’s success possible, nowhere is it mentioned that the patented and copyright-protected MOVA Contour technology was stolen from its inventor and developer, Rearden LLC, and its owner Rearden Mova LLC,” the suit reads.Nowhere is it mentioned that although Disney had previously contracted with Rearden LLC and its controlled entities on four previous major motion pictures to use MOVA Contour and knew of a Rearden Demand Letter to one of the thieves demanding immediate return of the stolen MOVA Contour system, Disney nonetheless contracted with the thieves to use the stolen MOVA Contour system.
- Man shot in leg while setting off illegal fireworks in SF
By Filipa Ioannou - Monday Jul 3, 2017
Man shot in leg while setting off illegal fireworks in SFA 27-year-old man was shot Saturday near San Francisco’s Sunnydale housing development while setting off illegal fireworks with a group of people, police said.The man was setting off fireworks near the intersection of Sunnydale Avenue and Hahn Street when another group of people came charging at the group, according to police.